We are live on ! Find out more
GRTX

Galera Therapeutics, Inc. Common Stock
GRTX

Delisted

GRTX was delisted on the 3rd of June, 2024.

Back to rankings

1 hedge funds and large institutions have $4 invested in Galera Therapeutics, Inc. Common Stock in 2026 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1
Holders Change
+1
Holders Change %
–
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GSEP
Golden State Equity Partners
California
+$4

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
GSEP
1
Golden State Equity Partners
California
$4 +$4 +93 New

GRTX Hedge Fund Activity: Q1 2026 in Review

1 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Galera Therapeutics, Inc. Common Stock (GRTX) for Q1 2026, worth a combined $4.

Buyers outnumbered sellers: 1 fund opened new GRTX positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Golden State Equity Partners, opening a new position worth an estimated $4.

  • 1 institutional investor held Galera Therapeutics, Inc. Common Stock (GRTX) as of Q1 2026, up from 0 in Q4 2025.
  • Funds reported $4 of Galera Therapeutics, Inc. Common Stock stock for Q1 2026.
  • 1 fund opened new Galera Therapeutics, Inc. Common Stock positions in Q1 2026 and 0 closed out, a net change of +1 holder.
  • The largest Galera Therapeutics, Inc. Common Stock buyer in Q1 2026 was Golden State Equity Partners, an estimated $4 added.

Based on aggregated 13F filings for Q1 2026.